China Dna Diagnostics Market Size & Outlook, 2025-2030
Global Market
Related Markets
China dna diagnostics market highlights
- The China dna diagnostics market generated a revenue of USD 579.5 million in 2024 and is expected to reach USD 1,171.3 million by 2030.
- The China market is expected to grow at a CAGR of 12.3% from 2025 to 2030.
- In terms of segment, pcr-based diagnostics was the largest revenue generating technology in 2024.
- NGS DNA Diagnosis is the most lucrative technology segment registering the fastest growth during the forecast period.
Dna diagnostics market data book summary
| Market revenue in 2024 | USD 579.5 million |
| Market revenue in 2030 | USD 1,171.3 million |
| Growth rate | 12.3% (CAGR from 2025 to 2030) |
| Largest segment | Pcr-based diagnostics |
| Fastest growing segment | NGS DNA Diagnosis |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics, Other Technologies |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
Other key industry trends
- In terms of revenue, China accounted for 5.5% of the global dna diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan dna diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,171.3 million by 2030.
In China, there has been a significant shift in death rates over the past 40 years from infectious diseases to NCDs. DNA testing can identify pathogens with high precision, enabling rapid and accurate diagnosis of infections like bacterial, viral, & fungal diseases.
This helps in tailoring the right treatment quickly. The main causes of this change have been risk factors like nutrition, physical inactivity, and smoking. Due to socioeconomic progress and demographic changes, China has experienced significant shifts in its mortality patterns over the past 40 years, moving from infectious diseases to NCDs.
This shift has been fueled by the widespread nature of risk factors, such as alcohol misuse, smoking, poor food, and physical inactivity; as a result, the leading causes of mortality in this country are now diabetes, cancer, Cardiovascular Disease (CVD), and Chronic Respiratory Diseases (CRD).
No credit card required*
Publish Date: Oct 14, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
DNA Diagnostics Market Scope
DNA Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
China DNA Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to DNA Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Pcr-Based Diagnostics was the largest segment with a revenue share of 54.62% in 2024.
Horizon Databook has segmented the China dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
In China, there has been a significant shift in death rates over the past 40 years from infectious diseases to NCDs. DNA testing can identify pathogens with high precision, enabling rapid and accurate diagnosis of infections like bacterial, viral, & fungal diseases.
This helps in tailoring the right treatment quickly. The main causes of this change have been risk factors like nutrition, physical inactivity, and smoking. Due to socioeconomic progress and demographic changes, China has experienced significant shifts in its mortality patterns over the past 40 years, moving from infectious diseases to NCDs.
This shift has been fueled by the widespread nature of risk factors, such as alcohol misuse, smoking, poor food, and physical inactivity; as a result, the leading causes of mortality in this country are now diabetes, cancer, Cardiovascular Disease (CVD), and Chronic Respiratory Diseases (CRD).
- China Dna Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
- PCR-based Diagnostics
- NGS DNA Diagnosis
- In-Situ Hybridization Diagnostics
- Microarrays-based Diagnostics
- Other Technologies
- China Dna Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
- Cancer Genetics Tests
- Infectious Diseases DNA Testing
- Newborn Genetic Screening
- Preimplantation & Reproductive Diagnosis
- Non-Infectious Diseases DNA Testing
- Prenatal DNA Carrier Screening
- Pharmacogenomics/Drug Metabolism
- Hematology & Immunology/Identity Diagnostics & Forensics
- Others
Reasons to subscribe to DNA Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of DNA Diagnostics Market Outlook databook
- Our clientele includes a mix of DNA Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China DNA Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China DNA Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
China Dna Diagnostics Market, 2018-2030 (US$M)
China dna diagnostics market statistics, by technology, 2018-2030 (US$M)
